Literature DB >> 11079218

Judging goodness must come before judging quality--but what is the good of health care?

G Mooney1.   

Abstract

The paper argues first that until it is known what the good of health care is there cannot be a judgement about what is better, and second that until it is known what is better there cannot be a judgement about what is quality. It is further suggested that in judging good and better with respect to health care as a social institution, there is no-one better placed to do this than the community. Too little is currently known about what communities want from their health services. Some suggestions as to how this situation might be improved in both principle and practice are discussed and the notion of 'communitarian claims' linked to conjoint analysis posited as a useful way forward. Such an approach will allow the development of a set of community-based principles--what is called a 'communitarian constitution'--on which to base the direction and objectives of health care.

Keywords:  Health Care and Public Health

Mesh:

Year:  2000        PMID: 11079218     DOI: 10.1093/intqhc/12.5.389

Source DB:  PubMed          Journal:  Int J Qual Health Care        ISSN: 1353-4505            Impact factor:   2.038


  3 in total

1.  Assessing Preferences Regarding Healthcare Interventions that Involve Non-Health Outcomes: An Overview of Clinical Studies.

Authors:  Brent C Opmeer; Corianne A J M de Borgie; Ben W J Mol; Patrick M M Bossuyt
Journal:  Patient       Date:  2010-03-01       Impact factor: 3.883

2.  Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry-Defining the "Goods" at Stake.

Authors:  Narcyz Ghinea; Miles Little; Wendy Lipworth
Journal:  J Bioeth Inq       Date:  2017-07-18       Impact factor: 1.352

3.  Women's experiences and views about costs of seeking malaria chemoprevention and other antenatal services: a qualitative study from two districts in rural Tanzania.

Authors:  Godfrey M Mubyazi; Paul Bloch; Pascal Magnussen; Øystein E Olsen; Jens Byskov; Kristian S Hansen; Ib C Bygbjerg
Journal:  Malar J       Date:  2010-02-17       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.